Clinical Trials Browser

Phase 1/2 × Extensive Stage Small Cell Lung Cancer × Paclitaxel × Clear all

NCT06016270 2025-09-05

A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer

Phase 1/2 Terminated

Extensive Stage Small Cell Lung Cancer